Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2024 | EBMT diagnostic criteria for TMA post-alloSCT and the role of complement activation

Jacopo Mariotti • 15 Apr 2024
EBMT 2024
General

Jacopo Mariotti, MD, Humanitas Research Hospital, Milan, Italy, presents a retrospective study on the efficacy of EBMT criteria in diagnosing thrombotic microangiopathy (TMA) post-allogeneic stem cell transplantation (alloSCT). The study confirms the criteria’s robust diagnostic capability, with patients meeting four or more criteria exhibiting poorer prognoses, especially those with C5b-9 complement activation. This interview took place at the 50th Annual Meeting of the EBMT in Glasgow, Scotland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Jacopo Mariotti

AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study 3:03
AlloSCT outcomes after immunotherapy vs chemotherapy in patients with R/R NHL: a retrospective study
Jacopo Mariotti • 15 Apr 2024
Checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to alloSCT for HL 2:28
Checkpoint inhibitors vs brentuximab vedotin as salvage therapy prior to alloSCT for HL
Jacopo Mariotti • 15 Apr 2024
Case report: unusual toxicity after treatment with brexu-cel 12:00
Case report: unusual toxicity after treatment with brexu-cel
Jacopo Mariotti • 13 Feb 2023

Related Videos

Opportunities and challenges for real-time AI decision support in transplant care 4:47
Opportunities and challenges for real-time AI decision support in transplant care
Amin Turki • 5 Sep 2025
How AI and digital innovation are transforming transplant care 4:02
How AI and digital innovation are transforming transplant care
Amin Turki • 5 Sep 2025
Bringing clinical trials to the community: current approaches at Sarah Cannon Research Institute 1:01
Bringing clinical trials to the community: current approaches at Sarah Cannon Research Institute
Krish Patel • 4 Sep 2025
Stem cell transplant in 2025: latest advances, improving GvHD, and key clinical trials 8:12
Stem cell transplant in 2025: latest advances, improving GvHD, and key clinical trials
Alexandra Gomez-Arteaga • 10 Sep 2025
The content of VJHemOnc is intended for healthcare professionals